187 related articles for article (PubMed ID: 38785942)
1. Development of a Novel In Silico Classification Model to Assess Reactive Metabolite Formation in the Cysteine Trapping Assay and Investigation of Important Substructures.
Umemori Y; Handa K; Yoshimura S; Kageyama M; Iijima T
Biomolecules; 2024 Apr; 14(5):. PubMed ID: 38785942
[TBL] [Abstract][Full Text] [Related]
2. Novel risk assessment of reactive metabolites from discovery to clinical stage.
Kakutani N; Nanayama T; Nomura Y
J Toxicol Sci; 2019; 44(3):201-211. PubMed ID: 30842372
[TBL] [Abstract][Full Text] [Related]
3. Predictive Model for Drug-Induced Liver Injury Using Deep Neural Networks Based on Substructure Space.
Kang MG; Kang NS
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946636
[TBL] [Abstract][Full Text] [Related]
4. Development of Prediction Models for Drug-Induced Cholestasis, Cirrhosis, Hepatitis, and Steatosis Based on Drug and Drug Metabolite Structures.
Shin HK; Kang MG; Park D; Park T; Yoon S
Front Pharmacol; 2020; 11():67. PubMed ID: 32116729
[TBL] [Abstract][Full Text] [Related]
5. Deep Learning Algorithm Based on Molecular Fingerprint for Prediction of Drug-Induced Liver Injury.
Yang Q; Zhang S; Li Y
Toxicology; 2024 Feb; 502():153736. PubMed ID: 38307192
[TBL] [Abstract][Full Text] [Related]
6. Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs.
Gómez-Lechón MJ; Tolosa L; Donato MT
J Appl Toxicol; 2016 Jun; 36(6):752-68. PubMed ID: 26691983
[TBL] [Abstract][Full Text] [Related]
7. A trapping method for semi-quantitative assessment of reactive metabolite formation using [35S]cysteine and [14C]cyanide.
Inoue K; Shibata Y; Takahashi H; Ohe T; Chiba M; Ishii Y
Drug Metab Pharmacokinet; 2009; 24(3):245-54. PubMed ID: 19571436
[TBL] [Abstract][Full Text] [Related]
8. Prediction and mechanistic analysis of drug-induced liver injury (DILI) based on chemical structure.
Liu A; Walter M; Wright P; Bartosik A; Dolciami D; Elbasir A; Yang H; Bender A
Biol Direct; 2021 Jan; 16(1):6. PubMed ID: 33461600
[TBL] [Abstract][Full Text] [Related]
9. Predicting hERG channel blockers with directed message passing neural networks.
Shan M; Jiang C; Chen J; Qin LP; Qin JJ; Cheng G
RSC Adv; 2022 Jan; 12(6):3423-3430. PubMed ID: 35425351
[TBL] [Abstract][Full Text] [Related]
10. AI/ML Models to Predict the Severity of Drug-Induced Liver Injury for Small Molecules.
Rao M; Nassiri V; Alhambra C; Snoeys J; Van Goethem F; Irrechukwu O; Aleo MD; Geys H; Mitra K; Will Y
Chem Res Toxicol; 2023 Jul; 36(7):1129-1139. PubMed ID: 37294641
[TBL] [Abstract][Full Text] [Related]
11. Comparing Machine Learning Algorithms for Predicting Drug-Induced Liver Injury (DILI).
Minerali E; Foil DH; Zorn KM; Lane TR; Ekins S
Mol Pharm; 2020 Jul; 17(7):2628-2637. PubMed ID: 32422053
[TBL] [Abstract][Full Text] [Related]
12. Direct Comparison of Total Clearance Prediction: Computational Machine Learning Model versus Bottom-Up Approach Using In Vitro Assay.
Kosugi Y; Hosea N
Mol Pharm; 2020 Jul; 17(7):2299-2309. PubMed ID: 32478525
[TBL] [Abstract][Full Text] [Related]
13. An In Silico Model for Predicting Drug-Induced Hepatotoxicity.
He S; Ye T; Wang R; Zhang C; Zhang X; Sun G; Sun X
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30999595
[TBL] [Abstract][Full Text] [Related]
14. Prediction models for drug-induced hepatotoxicity by using weighted molecular fingerprints.
Kim E; Nam H
BMC Bioinformatics; 2017 May; 18(Suppl 7):227. PubMed ID: 28617228
[TBL] [Abstract][Full Text] [Related]
15. Identification of intrinsic hepatotoxic compounds in Polygonum multiflorum Thunb. using machine-learning methods.
Hu X; Du T; Dai S; Wei F; Chen X; Ma S
J Ethnopharmacol; 2022 Nov; 298():115620. PubMed ID: 35963419
[TBL] [Abstract][Full Text] [Related]
16. The in silico identification of human bile salt export pump (ABCB11) inhibitors associated with cholestatic drug-induced liver injury.
Xi L; Yao J; Wei Y; Wu X; Yao X; Liu H; Li S
Mol Biosyst; 2017 Jan; 13(2):417-424. PubMed ID: 28092392
[TBL] [Abstract][Full Text] [Related]
17. Prediction of drug-induced liver injury and cardiotoxicity using chemical structure and in vitro assay data.
Ye L; Ngan DK; Xu T; Liu Z; Zhao J; Sakamuru S; Zhang L; Zhao T; Xia M; Simeonov A; Huang R
Toxicol Appl Pharmacol; 2022 Nov; 454():116250. PubMed ID: 36150479
[TBL] [Abstract][Full Text] [Related]
18. In Silico Prediction of Drug-Induced Liver Injury Based on Adverse Drug Reaction Reports.
Zhu XW; Li SJ
Toxicol Sci; 2017 Aug; 158(2):391-400. PubMed ID: 28521054
[TBL] [Abstract][Full Text] [Related]
19. Mechanism-based integrated assay systems for the prediction of drug-induced liver injury.
Kawaguchi M; Nukaga T; Sekine S; Takemura A; Susukida T; Oeda S; Kodama A; Hirota M; Kouzuki H; Ito K
Toxicol Appl Pharmacol; 2020 May; 394():114958. PubMed ID: 32198022
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the potential for drug-induced liver injury based on in vitro covalent binding to human liver proteins.
Usui T; Mise M; Hashizume T; Yabuki M; Komuro S
Drug Metab Dispos; 2009 Dec; 37(12):2383-92. PubMed ID: 19720731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
